Literature DB >> 14646027

Using a Rasch scale to characterize the clinical features of patients with a clinical diagnosis of uncertain, probable, or possible Alzheimer disease at intake.

Larry F Hughes1, Kyle Perkins, Benjamin D Wright, Heather Westrick.   

Abstract

OBJECTIVE: This study examined the clinical features of patients with clinical diagnoses of probable Alzheimer disease (AD), possible AD, and uncertain.
DESIGN: Case study comparing three groups of AD patients diagnosed at their initial visit to an Alzheimer outpatient clinic.
SETTING: Southern Illinois University School of Medicine's Center for Alzheimer Disease and Related Disorders (CADRD) assessment sites (20) in rural Illinois. PARTICIPANTS: 300 patients assessed at CADRD between January 1, 1994 and July 1, 2000. MEASUREMENTS: Patients were given an extensive clinical battery consisting of physical and neurologic examination, mental status testing including the Mini-Mental State Exam (MMSE), Short Blessed Dementia (SBD) and Blessed Dementia Scale (ADL), medical history evaluation, and laboratory tests. Other data included age at visit, gender, and medical history variables.
RESULTS: Mean MMSE, SBD, and ADL scores differed significantly between groups (p's < 0.01). In all three cognitive tests, the uncertain group was the least impaired while the probable AD group was the most impaired. A Rasch model indicated that only the cognitive measures were useful in discriminating between the three diagnostic groups.
CONCLUSION: In general, probable AD patients were distinguished from possible AD patients by the severity of their dementia as measured by the MMSE, ADL and SBD as well as Hachinski-Ischemic Score (HIS) scores. A Rasch model did well at predicting group membership based upon dementia measures only. The uncertain group differed from the AD groups in age and dementia severity as measured by the MMSE, ADL and SBD. Noting differences between this and previous studies, we speculate disparity may be related to differences in population ethnicity.

Entities:  

Mesh:

Year:  2003        PMID: 14646027     DOI: 10.3233/jad-2003-5503

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  4 in total

1.  Sustained attention in mild Alzheimer's disease.

Authors:  Anna Maria Berardi; Raja Parasuraman; James V Haxby
Journal:  Dev Neuropsychol       Date:  2005       Impact factor: 2.253

Review 2.  Understanding the Outcomes Measures used in Huntington Disease Pharmacological Trials: A Systematic Review.

Authors:  Noelle E Carlozzi; Angela Miciura; Nicholas Migliore; Praveen Dayalu
Journal:  J Huntingtons Dis       Date:  2014

3.  Decreased activity of daily living produced by the combination of Alzheimer's disease and lower limb fracture in elderly requiring nursing care.

Authors:  Toshimitsu Inagawa; Toshio Hamagishi; Yuji Takaso; Yoshiaki Hitomi; Yasuhiro Kambayashi; Yuri Hibino; Aki Shibata; Nguyen T M Ngoc; Jiro Okochi; Kotaro Hatta; Kiyoshi Takamuku; Tadashi Konoshita; Hiroyuki Nakamura
Journal:  Environ Health Prev Med       Date:  2012-05-11       Impact factor: 3.674

4.  The Role of Entropy in Construct Specification Equations (CSE) to Improve the Validity of Memory Tests: Extension to Word Lists.

Authors:  Jeanette Melin; Stefan Cano; Agnes Flöel; Laura Göschel; Leslie Pendrill
Journal:  Entropy (Basel)       Date:  2022-07-05       Impact factor: 2.738

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.